LAST UPDATED: May 08, 2026
5% 5-fluorouracil cream (5-FU) is a treatment that targets sun-damaged skin cells known as actinic keratoses, whilst leaving healthy skin cells alone. Actinic keratoses can be recognised as small flat lesions on sun-damaged skin that have a rough scaly surface. Calcipotriol ointment is normally used to treat psoriasis, an inflammatory skin condition; however, when used with 5% 5-fluorouracil cream it has been found to significantly reduce the length of treatment needed for actinic keratoses from around 4 weeks to 4-10 days.
The skin reaction may continue for up to 10 days, even after you have stopped using the creams following which your skin may peel. Usually, the skin will be back to normal within two weeks, which may be helped by the regular use of an emollient cream
The upper images show a typical reaction to treatment. The lower image shows the skin 3 months after the treatment had finished (click on the images to enlarge).
Actinic keratoses are a marker of the amount of sun that your skin has been exposed to, and to its susceptibility to sun-related change.
The creams will reduce the number of actinic keratoses, which in turn will reduce your risk of skin cancer.
Over time more actinic keratoses will develop, meaning that the treatment needs to be repeated. Rather than treating each actinic keratosis as it arises, it may be preferable to wait until you get a crop of new lesions (e.g. 5-10) before repeating the treatment.
You must not use the creams to treat any skin lesion that you do not recognise as either normal or an actinic keratosis, instead you must seek advice from a healthcare professional at the first possible opportunity.
Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.
Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.
The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes